Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738462 · ClinicalTrials.gov registry record
A Study to Evaluate the Conformis Hip System
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 49
- Enrollment target
NCT03738462: Clinical Trial study, sponsored by Restor3D.
NCT03738462 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738462 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This is a prospective multicenter study. Subjects will be implanted with a Conformis Hip System. If the surgeon intraoperatively decides to use the Cordera femoral stem, these patients will also be enrolled in the study and tracked as a subset of the Conformis Hip System patient population.The study sites will be located in the United States. The study subjects will be followed for 10 years post implantation.
Primary Outcome
Score 0-100 (successful result = post operative increase in Harris Hip Score of \> 20 points + radiographically stable implant + no additional femoral reconstruction; \< 70 = poor, 70-79 - fair, 80-89 = good, and 90-100 = excellent)
Interventions
- DEVICE Conformis Hip System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2022-06-06 |
Why NCT03738462 stopped before completion
NCT03738462 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Conformis Hip System is the first listed.
NCT03738462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03738462 about?
NCT03738462 is a clinical study titled "A Study to Evaluate the Conformis Hip System". This is a prospective multicenter study. Subjects will be implanted with a Conformis Hip System. If the surgeon intraoperatively decides to use the Cordera femoral stem, these patients will also be enrolled in the study and tracked as a subset of the Conformis Hip System patient population.The study...
What is the current status of trial NCT03738462?
This trial is currently terminated. The enrollment target is 49 participants. The study started on 2018-11-26. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT03738462?
The interventions under investigation include: Conformis Hip System (DEVICE).
Who is sponsoring clinical trial NCT03738462?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI